This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Gemcitabine.
|
If you are going to change the name, shouldn't you do it right, and rename it gemcitabine hydrochloride? Gene Nygaard 22:11, 1 Jun 2005 (UTC)
hai... hw many stages for preparation of this drug?? hyderabady_chemist —Preceding unsigned comment added by 68.102.250.74 ( talk) 21:39, 15 August 2010 (UTC)
This could benefit from a discussion of studies indicating the efficacy for various types of cancers and various stages. — Preceding unsigned comment added by R Stillwater ( talk • contribs) 03:47, 23 September 2011 (UTC)
Trial Sets New Standard for Pancreatic Cancer - Adjuvant combination almost doubled 5-year survival discusses ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma. Trial terminated early due to significant improvement in median survival. Will try to edit in when find the right place. - Rod57 ( talk) 20:27, 15 June 2016 (UTC)
This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Gemcitabine.
|
If you are going to change the name, shouldn't you do it right, and rename it gemcitabine hydrochloride? Gene Nygaard 22:11, 1 Jun 2005 (UTC)
hai... hw many stages for preparation of this drug?? hyderabady_chemist —Preceding unsigned comment added by 68.102.250.74 ( talk) 21:39, 15 August 2010 (UTC)
This could benefit from a discussion of studies indicating the efficacy for various types of cancers and various stages. — Preceding unsigned comment added by R Stillwater ( talk • contribs) 03:47, 23 September 2011 (UTC)
Trial Sets New Standard for Pancreatic Cancer - Adjuvant combination almost doubled 5-year survival discusses ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma. Trial terminated early due to significant improvement in median survival. Will try to edit in when find the right place. - Rod57 ( talk) 20:27, 15 June 2016 (UTC)